Clinical Trials Browser

Phase 2 × Gadolinium × 90 days × Clear all

NCT05692635 2026-03-20

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung